Full Text View
Tabular View
Study Results
Related Studies
Naltrexone and Varenicline: Weight Gain and Tolerability in Cigarette Smokers
This study has been completed.
Study NCT00502216   Information provided by Yale University

First Received on July 13, 2007.   Last Updated on August 30, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Smoking
Nicotine Dependence
Additional conditions recognized in this trial
Tobacco Use Disorder
Weight Gain
More general conditions related to this trial
Body Weight
Body Weight Changes
Habits
Mental Disorders
Signs and Symptoms
Substance-Related Disorders
Interventions listed in this trial
Naltrexone
Varenicline
More general drug interventions related to this trial
Central Nervous System Agents
Cholinergic Agents
Cholinergic Agonists
Molecular Mechanisms of Pharmacological Action
Narcotic Antagonists
Neurotransmitter Agents
Nicotinic Agonists
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Yale University
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institute on Drug Abuse (NIDA)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services